Edward James Schutter, a Director, acquired 451,512 Common Shares on a direct ownership basis at prices ranging from US$6.080 to US$6.100 between November 17th, 2021 and November 18th, 2021. This represents a $3,470,796 investment into the company's shares and an account share holdings change of greater than 100%.
Jason Wild, a Director and 10% Holder, acquired 3,058 Common Shares on a control or direction basis for registered holder Insight Wellness, 7,135 Common Shares on a control or direction basis for registered holder JW Growth Fund, 26,942 Common Shares on a control or direction basis for registered holder JW Opportunities Master Fund, and 62,865 Common Shares on a control or direction basis for registered holder JW Partners, LP at a price of $5.832 on November 23rd, 2021. This represents a $583,210 investment into the company's shares and an account share holdings change of 0.1%.
TerrAscend is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.
TerrAscend Corp is a Canada-based company engaged in providing products, brands, and services to the cannabinoid market. The Company, through its subsidiary TerrAscend Canada Inc., is a producer of medical and adult use cannabis. It also operates through various businesses, including The Apothecarium, a cannabis dispensary with retail locations in California and Nevada; Arise Bioscience Inc., a manufacturer and distributor of hemp-derived products; Ascendant Laboratories Inc., a biotechnology and licensing company focused on cannabinoid expressing plants; Solace RX Inc., a Drug Preparation Premises (DPP) focused on the development of formulations and delivery forms; and Valhalla Confections, a manufacturer of premium cannabis-infused edibles. It has operations in three more retail dispensaries located in Bethlehem, Allentown and Stroudsburg.
No Comments